Launch of treatment for hepatitis C in the United Kingdom.
D017277:Drug Approval; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011994:Recombinant Proteins; D006113:United Kingdom
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins